New Kids on the Block: pipeline, approvals, and reimbursement

August 31, 2022

This activity will provide Vizient members with the most current information on newly approved medications and emerging drug therapies, including clinical implications. This activity will also include strategies that can be used to charge appropriately for new medications and how facilities will be reimbursed.

Target Audience

Pharmacists and Pharmacy Technicians

Learning Objectives

Learning objectives

  1. Identify impactful pipeline medications and discuss the Vizient process for monitoring the pipeline.
  2. Review recent medication approvals with significant clinical impact.
  3. Evaluate reimbursement from Centers for Medicare and Medicaid Services for new medications.


Pharmacy technician learning objectives

  1. Identify impactful pipeline medications and discuss the Vizient process for monitoring the pipeline.

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
Course expires: 
Event starts: 
08/31/2022 - 9:00am CDT
Event ends: 
08/31/2022 - 10:00am CDT
Live activity
United States

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

Ineligible companies those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

FDA Off-Label Use

Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.


Absence of Relevant Financial Relationships

The following planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.

Off-label/unapproved drug uses or products are mentioned within this activity.

Planning committee:
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director

Michelle Smith, PharmD, BCPS
Pharmacy Executive, MWPC Pharmacy Network

Amanda Frick, PharmD, BCPS
Sr Clinical Manager

Carolyn Liptak, MBA, RPh
Pharmacy Executive Director

John Schoen, PharmD, BCPS
Sr. Clinical Manager of Drug Information




Joint Accreditation Statement:

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement:


Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.

Universal Activity Number: JA0006103-0000-22-055-L01-P and JA0006103-0000-22-055-L01-T


Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Please login or register to take this course.